COMMUNIQUÉS West-GlobeNewswire

Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
26/03/2024
TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Further to the announcement by Psyence Group Inc (" Psyence " or the " Company ") (CSE:PSYG) of its plans for the strategic restructuring of its non-clinical business through [...]
Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
26/03/2024
MELBOURNE, Australia and SAN FRANCISCO, March 27, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease [...]
Hapbee Announces Closing of Private Placement
26/03/2024
Company Raises $2.8 Million From Qualified Investors to Fund Product Development, Market Expansion and Manufacturing VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB [...]
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
26/03/2024
WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on [...]
Grant Christie Joins Acentra Health as Senior Vice President of Market Strategy and Solutions
26/03/2024
MCLEAN, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, [...]
Better Choice Company Initiates Legal Action Against Alphia, a Portfolio Company of Private Equity Firm PAI
26/03/2024
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, initiated a legal action to enforce a right of first refusal [...]
Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID
26/03/2024
- New patent would extend coverage and expand potential value of Virios’ antiviral pipeline globally – - Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses reactivation - - [...]
Les scientifiques de l’hôpital spécialisé et centre de recherche King Faisal contribuent aux efforts internationaux de lutte contre l’antibiorésistance des bactéries en identifiant une toute nouvelle espèce de bactérie : Riyadhensis
26/03/2024
RIYAD, Arabie saoudite, 26 mars 2024 (GLOBE NEWSWIRE) -- Des scientifiques de l’hôpital spécialisé et centre de recherche King Faisal (ou « KFSH&RC » pour King Faisal Specialist Hospital and Research Centre ) ont [...]
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
26/03/2024
OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) announced today that management will host a conference call and webcast to discuss the Company’s Q4/ [...]
Save the date for ALK’s Capital Markets Day on 4 June 2024
26/03/2024
ALK (ALKB:DC / OMX: ALK B / AKBLF) will host a Capital Markets Day on 4 June 2024 in the afternoon at the company’s headquarters in Hørsholm, Denmark. At the Capital Markets Day, the Board of Management will elaborate [...]
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
26/03/2024
Data Demonstrated the Use of MyoVista wavECGTM for Screening Preoperative Patients for LVDD Can Be Recommended Southlake, Texas, March 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences ( [...]
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
26/03/2024
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited commercial launch initiated [...]
American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO
26/03/2024
Dr. Bates, Pioneering Neurosurgeon and Philanthropist, passed on March 19, 2024 SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading [...]
Forbes Recognizes Luna as a Top-Rated Employer in its List of America’s Best Employers for 2024
26/03/2024
NASHVILLE, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- Luna , the leading provider of in-home, in-person physical therapy (PT), is proud to announce its ranking on Forbes annual list of America’s Best Startup Employers [...]
Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L
26/03/2024
Nationally Established Q Code Will Further Support the Use of Biovance® 3L by Physicians to Treat Wound Care Patients in Office Settings FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: [...]
PharmAla Biotech Signs Sale Agreement with Numinus
26/03/2024
LaNeo Product Data submitted for a Clinical Trial in Canada TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA, OTC:MDXXF), a biotechnology company [...]
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
26/03/2024
- Company to host conference call and webcast featuring key opinion leaders on Monday, April 8, 2024 at 8:00 a.m. ET - BOSTON, March 26, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “ [...]
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
26/03/2024
The first trial using a C1 produced monoclonal antibody provides equivalent protection against SARS-CoV-2 in hamster and nonhuman primate models compared to monoclonal antibody produced in CHO. JUPITER, Fla., March 26, [...]
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
26/03/2024
FREMONT, CA, March 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS ( [...]

Pages